PERFORMANCE ASSESSMENT OF AN ARTIFICIAL INTELLIGENCE CHATBOT IN CLINICAL VITREORETINAL SCENARIOS

*Department of Ophthalmology, Corewell Health William Beaumont University Hospital, Royal Oak, Michigan;

†Manhattan Retina and Eye Consultants, New York, New York;

‡Department of Ophthalmology, New York University School of Medicine, New York, New York;

§Icahn School of Medicine of Mount Sinai, New York, New York;

¶Associated Retinal Consultants, Royal Oak, Michigan.

Reprint requests: Tedi Begaj, MD, Associated Retinal Consultants, 3555 West Thirteen Mile Road, Suite LL-20, Royal Oak, MI, 48073; e-mail: [email protected]

Tedi Begaj: Financial disclosures: Consultant fees for Regenxbio and Eyepoint. Ravi Parikh: Financial disclosures: Consultant fees for Anthem, Blue Cross Blue Shield, and GLG Surveys. Avnish Deobhakta: Financial disclosures: Consultant fees for Alimera Sciences and founder of Avant Sciences.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.retinajournal.com).

Comments (0)

No login
gif